411 related articles for article (PubMed ID: 20350958)
1. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
Brennan RM; Burrows JM; Bell MJ; Bromham L; Csurhes PA; Lenarczyk A; Sverndal J; Klintenstedt J; Pender MP; Burrows SR
Mult Scler; 2010 Jun; 16(6):643-51. PubMed ID: 20350958
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus genotypes in multiple sclerosis.
Lindsey JW; Patel S; Zou J
Acta Neurol Scand; 2008 Feb; 117(2):141-4. PubMed ID: 18184350
[TBL] [Abstract][Full Text] [Related]
3. Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Lindsey JW; Hatfield LM; Crawford MP; Patel S
Mult Scler; 2009 Feb; 15(2):153-8. PubMed ID: 18845656
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and multiple sclerosis.
Pohl D
J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
[TBL] [Abstract][Full Text] [Related]
5. High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis.
Santón A; Cristóbal E; Aparicio M; Royuela A; Villar LM; Alvarez-Cermeño JC
Mult Scler; 2011 Nov; 17(11):1295-300. PubMed ID: 21757537
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
DeLorenze GN; Munger KL; Lennette ET; Orentreich N; Vogelman JH; Ascherio A
Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus candidate genes and multiple sclerosis.
Claire Simon K; Schmidt H; Loud S; Ascherio A
Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and multiple sclerosis.
Salvetti M; Giovannoni G; Aloisi F
Curr Opin Neurol; 2009 Jun; 22(3):201-6. PubMed ID: 19359987
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis is linked to Epstein-Barr virus infection.
Haahr S; Höllsberg P
Rev Med Virol; 2006; 16(5):297-310. PubMed ID: 16927411
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus cause of multiple sclerosis.
Tselis A
Curr Opin Rheumatol; 2012 Jul; 24(4):424-8. PubMed ID: 22617821
[TBL] [Abstract][Full Text] [Related]
14. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
16. Environmental risk factors for multiple sclerosis. Part I: the role of infection.
Ascherio A; Munger KL
Ann Neurol; 2007 Apr; 61(4):288-99. PubMed ID: 17444504
[TBL] [Abstract][Full Text] [Related]
17. EBNA1 and LMP1 variants in multiple sclerosis cases and controls.
Simon KC; Yang X; Munger KL; Ascherio A
Acta Neurol Scand; 2011 Jul; 124(1):53-8. PubMed ID: 20636447
[TBL] [Abstract][Full Text] [Related]
18. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.
Gronen F; Ruprecht K; Weissbrich B; Klinker E; Kroner A; Hofstetter HH; Rieckmann P
J Neuroimmunol; 2006 Nov; 180(1-2):185-92. PubMed ID: 17023054
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and multiple sclerosis.
Lovett-Racke AE; Racke MK
Arch Neurol; 2006 Jun; 63(6):810-1. PubMed ID: 16769860
[No Abstract] [Full Text] [Related]
20. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
Wagner HJ; Munger KL; Ascherio A
Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
